ALX ONCOLOGY
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Mar 2026)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87822154
- Registration number
- 5938756
- Mark type
- Stylized text
- Filed
- 06 Mar 2018
- Published for opposition
- 14 Aug 2018
- Registered
- 17 Dec 2019
- Attorney of record
- Rachelle A. Dubow, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of cancer
Owner
- ALX Oncology, Inc., San Francisco, CA, US
- ALX Oncology, Inc., Burlingame, CA, US
- ALX Oncology, Inc., Burlingame, CA, US
Prosecution history
- 04 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Oct 2019 — USE AMENDMENT FILED
- 24 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 19 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Mar 2019 — SOU EXTENSION 1 GRANTED
- 15 Mar 2019 — SOU EXTENSION 1 FILED